Skip to main content
. 2017 Aug 10;82:431–440. doi: 10.12659/PJR.901785

Table 4.

Percentage changes in total bilirubin values after stenting, survival and primary stent patency duration in patients with different types of obstruction treated with unilobar or bilobar stenting and partial- or whole-liver drainage. Similar table design was used in a study by Brountzos et al. [4].

Obstruction type No. Decrease in TBIL levels after stenting, % P value Survival P value Primary patency P value
Distal 77 52.4 (32.7–65.4) 86.7±13.9 81.2±13.1
Bismuth I 69 52.9 (22–68.2) 187.3±44 155.3±35.1
Bismuth II
Unilobar stenting
Bilobar stenting
22
19
3
34.5
33.8
39.1
(7.9–57)
(27.6–52.2)
(19.2–58.3)
0.948 225.9±98.6
164.2±83
249.2
0.340 161.9±77.1
118.9±63.6
176.9
0.424
Bismuth III
Unilobar stenting
Bilobar stenting
37
25
12
38.5
37.2
43.4
(8.8–60.6)
(16.1–60.9)
(12.1–61.9)
0.357 134.4±23
98.1±28
200.7±98.1
0.032 106.9±21
70±21.2
178.8±22
0.007
Bismuth IV
Unilobar stenting
Bilobar stenting
17
11
6
35.3
22.0
72.4
(2.2–72.7)
(7.4–67.3)
(65–82.6)
< 0.001 80.9±22.6
47±12
123±54.2
0.257 65.8±20.8
47±13.9
123±54.2
0.280
Method of liver parenchyma drainage
Partial-liver
Whole-liver
55
167
35.6
52.5
(0.5–60.9)
(26.2–70)
< 0.001 115.2±31.1
153.2±24.6
0.035 77.5±22.2
125.2±18
0.044

TBIL – total bilirubin. Percentage changes in bilirubin values after stenting are expressed as median (interquartile range). Survival and primary stent patency are expressed as estimated mean ± standard error. The decrease in serum bilirubin levels was statistically significant for all types of obstruction according to the Bismuth-Corlette classification (P<0.05).